Buprenorphine Drug Assistance Program (BUP-DAP) Grant

The Buprenorphine Drug Assistance Program (BUP-DAP) provides vital support for low-income individuals diagnosed with Opioid Use Disorder (OUD) in Washington, D.C. By offering approved Medication for Opioid Use Disorder (MOUD), the program enhances access to quality treatment for those lacking health care coverage. It aims to integrate these individuals into a comprehensive system of care, fostering recovery and improving overall community health. This initiative emphasizes collaboration with Federally Qualified Health Centers (FQHCs) to maximize outreach and effectiveness.

Note: 1) Pre-Application Conference is indicated above as Pre-proposal. 2) Letter of Intent Due Date is indicated above as the due date for Letter of Inquiry.
Department of Behavioral Health
The Department of Behavioral Health provides prevention, intervention and treatment services and supports for children, youth and adults with mental and/or substance use disorders including emergency psychiatric care and community-based outpatient and residential services.
DBH serves eligible adults, children and youth and their families through a network of community based providers and unique government delivered services. It operates Saint Elizabeths Hospital—the District’s inpatient psychiatric facility.
Program Description
This RFA identifies opportunities to provide approved MOUD to low-income clients diagnosed with OUD who have limited or no health care coverage. BUPDAP brings individuals into a system of care and provides them with quality treatment and services.

Eligibility

Physically located and currently operating in the District of Columbia.Federally Qualified Health Center (FQHC)